Comparative Pharmacology
Head-to-head clinical analysis: GOLYTELY versus NULYTELY.
Head-to-head clinical analysis: GOLYTELY versus NULYTELY.
GOLYTELY vs NULYTELY
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Polyethylene glycol 3350 is an osmotic laxative that induces diarrhea by retaining water in the bowel lumen through osmotic activity. Electrolytes (sodium sulfate, potassium chloride, sodium bicarbonate) prevent significant electrolyte absorption or loss.
Polyethylene glycol (PEG) 3350 is an osmotic agent that induces diarrhea by drawing water into the gastrointestinal tract, thereby cleansing the bowel. Sodium sulfate and electrolytes (sodium, potassium, bicarbonate) are added to prevent fluid and electrolyte shifts.
240 mL (oral) every 10 minutes until 4 L consumed or rectal effluent is clear; typically 4 L total over 3-4 hours.
4 liters orally of the reconstituted solution as a single dose for colonoscopy preparation, typically administered in divided doses (e.g., 240 mL every 10 minutes) until rectal effluent is clear. Alternatively, a split-dose regimen: half the solution evening before, half on the day of procedure.
None Documented
None Documented
Not applicable (PEG 3350 is not significantly absorbed; effective half-life in GI tract is approximately 2-4 hours for colonic clearance).
Not applicable; NULYTELY is not systemically absorbed in significant amounts, so a terminal elimination half-life is not defined. The drug acts locally in the gastrointestinal tract.
Primarily fecal elimination of unabsorbed polyethylene glycol 3350. Minimal systemic absorption (<0.06%), less than 0.06% recovered in urine as intact PEG 3350; electrocytes and sulfate (from sodium sulfate) are renally excreted.
NULYTELY (polyethylene glycol 3350) is minimally absorbed systemically (<0.06%). The primary route of elimination is fecal excretion of the intact polymer. Renal excretion is negligible (<0.02%).
Category C
Category C
Osmotic Laxative
Osmotic Laxative